Skip to content

Assessment of the V600E Mutation in the B-RAF Gene in Chronic Lymphoproliferative Disease

Assessment of the V600E Mutation in the B-RAF Gene in Chronic Lymphoproliferative Disease.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01720758
Acronym
B-RAF V600E
Enrollment
20
Registered
2012-11-02
Start date
2012-11-30
Completion date
2013-04-30
Last updated
2017-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hairy Cell Leukemia, Splenic Marginal Zone Lymphoma

Brief summary

The presence of a specific mutation in the gene known as B-RAF has been found in patients who have Hairy Cell Leukemia. In this study this specific mutation known as V600E will be ascertained in peripheral blood samples of patients who have this disease and in a group of patients who have a similar chronic lymphoproliferative conditions such as splenic marginal lymphoma. The finding of this specific mutation will help to verify or exclude the diagnosis of Hairy Cell Leukemia and determine whether patients are in remission.

Interventions

None listed

Sponsors

HaEmek Medical Center, Israel
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients over the age of 18 years -

Exclusion criteria

Patients less than 18 years in age or mentally defectives. \-

Design outcomes

Primary

MeasureTime frame
detection of the B-RAF V600E mutation2 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026